Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home

Polyceutix

SME

example.comCopenhagen, Denmark
21 profile visits

About

Polyceutix' lead is a first-in-class cancer immunotherapy that lets the immune system see thousands of tumor-specific proteins at once instead of a few selected targets. This has translated into strong preclinical efficacy of our ready drug candidate.

We are further using our Native Nanodisc platform to generate novel targeted therapies for membrane protein related autoimmune diseases in neurology and cardiology.

Social media

What is your business/industry sector?

Biotech, Pharma and Cosmetics

Representatives

Mads Holmegaard Sørensen

Co-founder

Polyceutix